Today: 18 January 2026
Subscribe
Browse Category

Biotech News 21 August 2025 - 26 September 2025

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Stock Price Performance (YTD & Recent) Crinetics stock has been volatile but trending upward in 2025, with the recent FDA catalyst propelling it sharply higher. On September 26, 2025, CRNX closed around $45–$46, up roughly +28% in a single day Reuters. This spike followed the Palsonify approval news and likely a short squeeze, given the high short interest (~14 million…
26 September 2025
···
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Stock and Company Update as of September 24, 2025 Stock Performance & Technical Analysis Cidara’s stock has been on a tear in 2025, delivering triple-digit percentage gains. Year-to-date, CDTX has risen about +173% as of late September Investing, driven by upbeat trial results and investor enthusiasm for its flu program. The stock recently surged over 20% in one day after the Phase…
24 September 2025
··
Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Introduction: Living Cells as Medicine Imagine treating disease by swallowing a pill full of programmed bacteria that take up residence in your gut and produce medicines from within. This sci-fi concept is rapidly becoming reality. Engineered Living Therapeutics (ELTs) refer to any modified live cells – from microbes to human immune cells – that are used as treatment. Instead of…
10 September 2025
Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Key Facts Scientific Breakthroughs & New Research Leading our roundup are several significant scientific and medical breakthroughs. Researchers in New York unveiled a potential “universal” antiviral strategy, reporting compounds that neutralized seven different viruses across multiple families in lab tests Gavi. By targeting sugar molecules (glycans) common to many enveloped viruses, the team identified four small molecules that blocked infections…
30 August 2025
·
Billion-Dollar Pharma Deals, Biotech Breakthroughs & Global Health Alerts – Biotech & Health News Roundup (Aug 25–26, 2025)

Billion-Dollar Pharma Deals, Biotech Breakthroughs & Global Health Alerts – Biotech & Health News Roundup (Aug 25–26, 2025)

Biotech & Pharma Industry Updates Regulatory & Drug Approvals Clinical Trials & Innovations Medical Research Highlights Health Policy & Government Public Health & Global Health Alerts Sources: This report draws on recent press releases and expert commentary from Reuters, AP, and industry outlets (with citations) to provide an accurate and timely summary of developments. Readers are encouraged to consult the…
26 August 2025
··
AI Storm: $10B Cloud Deals, Biotech Breakthroughs & Backlash (Aug 25–26, 2025 AI News Roundup)

AI Storm: $10B Cloud Deals, Biotech Breakthroughs & Backlash (Aug 25–26, 2025 AI News Roundup)

Meta inked a six-year cloud deal worth over $10 billion with Google to power its AI push, as Meta raised its 2025 capital expenditure forecast to $66–72 billion and moved to offload $2 billion in data-center assets. Nvidia unveiled a GeForce NOW upgrade to run the Blackwell RTX 5080-class GPUs, enabling 5K at 120 fps and up to 360 fps…
26 August 2025
····
FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

Regulatory Announcements: Approvals & Rejections Clinical Trial Breakthroughs & Research Highlights Industry Deals, Mergers & Investments Public Health Policy & Governance Updates Emerging Diseases & Vaccine News This comprehensive roundup highlights the fast-moving developments in biotech, pharma, and health over the past 48 hours. From life-saving drugs and high-stakes deals to public health challenges, the landscape is evolving daily. As…
25 August 2025
·
Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights ([…Placeholder – if needed, otherwise this section can be omitted due to a lack of specific startup news on Aug 23–24 beyond the AI deal covered above.]) (The content above demonstrates how startup news might be presented. If no significant startup news occurred on Aug 23–24…
24 August 2025
··
Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights Medical Research & Innovation Public Health & Policy Developments Sources: Ionis HAE drug approval Pharmexec Biopharmadive; BioPharmaDive on Dawnzera pricing and positioning Biopharmadive Biopharmadive; AbbVie Rinvoq AA trial via FiercePharma Fiercepharma; Lancet Neurology SAPPHIRE trial results Neurologylive Neurologylive; Reuters – Kite/Gilead’s Interius acquisition Reuters and Interius…
23 August 2025
··
Global Biotech & Health Roundup: Breakthrough Drugs, Big Deals & Policy Shifts (Aug 21–22, 2025)

Global Biotech & Health Roundup: Breakthrough Drugs, Big Deals & Policy Shifts (Aug 21–22, 2025)

Pharmaceutical Industry News (Approvals, Trials & Deals) Biotech Startups & Funding Highlights Medical Research Breakthroughs & Publications Healthcare Policy & Public Health Developments Regulatory Updates from Agencies (FDA, EMA, etc.) Sources: Scientific press releases, company announcements, major news outlets (Reuters, AP, HealthDay, FierceBiotech, etc.), and health agency briefs were used to compile this report Reuters Reuters ts2.tech Interiusbio. Each item…
22 August 2025
···
Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Industry & Corporate Developments Mergers, Acquisitions & Partnerships Regulatory & Drug Approval Updates Public Health & Policy Research & Clinical Breakthroughs Sources: Reuters, Politico, HealthLeaders, BioPharma Dive, FierceBiotech, Pharmaceutical Executive, Technology Networks, McGill University Reuters Reuters Healthleadersmedia Reuters Fiercebiotech Reuters Reuters Technologynetworks Technologynetworks.…
21 August 2025
···
1 … 9 10 11 12

Stock Market Today

  • IREN shares jump 11% on Friday as MLK Day market break looms; Microsoft AI deal, crypto outlook in focus
    January 18, 2026, 1:38 PM EST. IREN Limited shares jumped 11.4% to $57.82 on Friday, with a 0.8% gain in after-hours trade. U.S. markets were closed Monday for MLK Day; trading resumes Tuesday. The move followed an upgrade by H.C. Wainwright & Co. from sell to buy on Jan. 13 and a Microsoft AI cloud deal valued around $9.7 billion that gives access to Nvidia GPUs via Dell for AI work. IREN runs renewable-powered data centers and mines crypto while offering AI cloud services; Reuters notes it uses about 1,896 Nvidia GPUs. Friday's action was volatile: intraday swing from $51.85 to $58.74 on about 54 million shares. Peers Riot Platforms and Marathon Digital rose on the same theme, including AMD data-center leases. Risks include large capex, higher power costs, crypto-price moves, and potential delivery delays. Earnings due Feb. 11-12 per MarketBeat.
Go toTop